-
2
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD38XivVOmsrY%3D 11961152
-
Angulo P. Nonalcoholic fatty liver disease. New Engl J Med. 2002;346:1221-31.
-
(2002)
New Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
3
-
-
84880419922
-
Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
-
1:CAS:528:DC%2BC3sXhtFeqt77J 23855299
-
Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28:68-76.
-
(2013)
J Gastroenterol Hepatol
, vol.28
, pp. 68-76
-
-
Schuppan, D.1
Schattenberg, J.M.2
-
4
-
-
84880008350
-
The expanding role of fish models in understanding non-alcoholic fatty liver disease
-
3701210 1:CAS:528:DC%2BC3sXht1Chsr3O 23720231
-
Asaoka Y, Terai S, Sakaida I, Nishina H. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis Model Mech. 2013;6:905-14.
-
(2013)
Dis Model Mech
, vol.6
, pp. 905-914
-
-
Asaoka, Y.1
Terai, S.2
Sakaida, I.3
Nishina, H.4
-
5
-
-
38749152419
-
Evolving trends in nonalcoholic fatty liver disease
-
1:CAS:528:DC%2BD1cXhtlymsL4%3D 18249301
-
Delgado J-S. Evolving trends in nonalcoholic fatty liver disease. Eur J Intern Med. 2008;19:75-82.
-
(2008)
Eur J Intern Med
, vol.19
, pp. 75-82
-
-
Delgado, J.-S.1
-
7
-
-
34250356015
-
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
-
1:CAS:528:DC%2BD2sXnvFaltLw%3D 17476695
-
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366-74.
-
(2007)
Hepatology
, vol.45
, pp. 1366-1374
-
-
Yamaguchi, K.1
Yang, L.2
McCall, S.3
Huang, J.4
Yu, X.X.5
Pandey, S.K.6
-
8
-
-
84857949744
-
Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: Role for oxidative-nitrosative stress
-
3312982 1:CAS:528:DC%2BC38XktlKqsrY%3D 22366714
-
Lupachyk S, Watcho P, Hasanova N, Julius U, Obrosova IG. Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radic Biol Med. 2012;52:1255-63.
-
(2012)
Free Radic Biol Med
, vol.52
, pp. 1255-1263
-
-
Lupachyk, S.1
Watcho, P.2
Hasanova, N.3
Julius, U.4
Obrosova, I.G.5
-
9
-
-
84878437339
-
Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects
-
3690693 1:CAS:528:DC%2BC3sXhtVWmtrbI 23529132
-
Liang H, Tantiwong P, Sriwijitkamol A, Shanmugasundaram K, Mohan S, Espinoza S, et al. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects. J Physiol. 2013;591:2897-909.
-
(2013)
J Physiol
, vol.591
, pp. 2897-2909
-
-
Liang, H.1
Tantiwong, P.2
Sriwijitkamol, A.3
Shanmugasundaram, K.4
Mohan, S.5
Espinoza, S.6
-
10
-
-
84856400955
-
High free fatty acids level related with cardiac dysfunction in obese rats
-
1:CAS:528:DC%2BC38XhsFGjtrg%3D 22088789
-
Sun X, Pan H, Tan H, Yu Y. High free fatty acids level related with cardiac dysfunction in obese rats. Diabetes Res Clin Pract. 2012;95:251-9.
-
(2012)
Diabetes Res Clin Pract
, vol.95
, pp. 251-259
-
-
Sun, X.1
Pan, H.2
Tan, H.3
Yu, Y.4
-
11
-
-
0034652225
-
Lipotoxic heart disease in obese rats: Implications for human obesity
-
26513 1:CAS:528:DC%2BD3cXhsFCrt7Y%3D 10677535
-
Zhou Y-T, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784-9.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 1784-1789
-
-
Zhou, Y.-T.1
Grayburn, P.2
Karim, A.3
Shimabukuro, M.4
Higa, M.5
Baetens, D.6
-
12
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
15915461
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
-
13
-
-
78651089694
-
Animal models of nonalcoholic fatty liver disease
-
21119613
-
Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2011;8:35-44.
-
(2011)
Nat Rev Gastroenterol Hepatol
, vol.8
, pp. 35-44
-
-
Hebbard, L.1
George, J.2
-
14
-
-
33644955272
-
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
-
2517349 1:CAS:528:DC%2BD28XislOksbc%3D 16436109
-
Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1-16.
-
(2006)
Int J Exp Pathol
, vol.87
, pp. 1-16
-
-
Anstee, Q.M.1
Goldin, R.D.2
-
15
-
-
0037453056
-
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
-
152249 1:CAS:528:DC%2BD3sXisVCnsLs%3D 12629214
-
Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A. 2003;100:3077-82.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 3077-3082
-
-
Listenberger, L.L.1
Han, X.2
Lewis, S.E.3
Cases, S.4
Farese, R.V.5
Ory, D.S.6
-
16
-
-
77955690182
-
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
-
20683968
-
Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774-88.
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
17
-
-
0035896515
-
Natural ceramide reverses Fas resistance of acid sphingomyelinase-/- hepatocytes
-
1:CAS:528:DC%2BD3MXitFKgtr4%3D 11096096
-
Paris F, Grassmé H, Cremesti A, Zager J, Fong Y, Haimovitz-Friedman A, et al. Natural ceramide reverses Fas resistance of acid sphingomyelinase-/- hepatocytes. J Biol Chem. 2001;276:8297-305.
-
(2001)
J Biol Chem
, vol.276
, pp. 8297-8305
-
-
Paris, F.1
Grassmé, H.2
Cremesti, A.3
Zager, J.4
Fong, Y.5
Haimovitz-Friedman, A.6
-
18
-
-
84892952980
-
Production of reactive oxygen species in the diabetic heart
-
1:CAS:528:DC%2BC2cXltFKhtrc%3D 24334638
-
Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, et al. Production of reactive oxygen species in the diabetic heart. Circ J. 2014;78:300-6.
-
(2014)
Circ J
, vol.78
, pp. 300-306
-
-
Teshima, Y.1
Takahashi, N.2
Nishio, S.3
Saito, S.4
Kondo, H.5
Fukui, A.6
-
19
-
-
38049186666
-
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
-
1:CAS:528:DC%2BD1cXktVWqtQ%3D%3D 17951222
-
Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee J-H, et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res. 2008;49:84-97.
-
(2008)
J Lipid Res
, vol.49
, pp. 84-97
-
-
Han, M.S.1
Park, S.Y.2
Shinzawa, K.3
Kim, S.4
Chung, K.W.5
Lee, J.-H.6
-
20
-
-
34347235098
-
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
-
1:CAS:528:DC%2BD2sXotlCitLg%3D 17618857
-
Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007;6:69-78.
-
(2007)
Cell Metab
, vol.6
, pp. 69-78
-
-
Monetti, M.1
Levin, M.C.2
Watt, M.J.3
Sajan, M.P.4
Marmor, S.5
Hubbard, B.K.6
-
21
-
-
84867861053
-
Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models
-
1:CAS:528:DC%2BC38XhslSntrvO 23038002
-
Miyashita T, Toyoda Y, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. J Toxicol Sci. 2012;37:931-42.
-
(2012)
J Toxicol Sci
, vol.37
, pp. 931-942
-
-
Miyashita, T.1
Toyoda, Y.2
Tsuneyama, K.3
Fukami, T.4
Nakajima, M.5
Yokoi, T.6
-
22
-
-
49449099979
-
Osthole regulates enzyme protein expression of CYP7A1 and DGAT2 via activation of PPARα/γ in fat milk-induced fatty liver rats
-
1:CAS:528:DC%2BD1cXpsFOjsLs%3D
-
Zhang Y, Xie M-L, Xue J, Gu Z-L. Osthole regulates enzyme protein expression of CYP7A1 and DGAT2 via activation of PPARα/γ in fat milk-induced fatty liver rats. J Asian Nat Prod Res. 2008;10:797-802.
-
(2008)
J Asian Nat Prod Res
, vol.10
, pp. 797-802
-
-
Zhang, Y.1
Xie, M.-L.2
Xue, J.3
Gu, Z.-L.4
-
23
-
-
84897382346
-
Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats
-
3906058 24489777
-
Li S, Meng F, Liao X, Wang Y, Sun Z, Guo F, et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9, e86724.
-
(2014)
PLoS One
, vol.9
-
-
Li, S.1
Meng, F.2
Liao, X.3
Wang, Y.4
Sun, Z.5
Guo, F.6
-
24
-
-
84907598757
-
Long-term intake of soyabean phytosterols lowers serum TAG and NEFA concentrations, increases bile acid synthesis and protects against fatty liver development in dyslipidaemic hamsters
-
1:CAS:528:DC%2BC2cXhtlyku77M 24932972
-
Laos S, Caimari A, Crescenti A, Lakkis J, Puiggròs F, Arola L, et al. Long-term intake of soyabean phytosterols lowers serum TAG and NEFA concentrations, increases bile acid synthesis and protects against fatty liver development in dyslipidaemic hamsters. Br J Nutr. 2014;112:663-73.
-
(2014)
Br J Nutr
, vol.112
, pp. 663-673
-
-
Laos, S.1
Caimari, A.2
Crescenti, A.3
Lakkis, J.4
Puiggròs, F.5
Arola, L.6
-
25
-
-
0035937174
-
Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia
-
1:CAS:528:DC%2BD3MXhs1Kmsbg%3D 11096093
-
Lee Y, Wang M-Y, Kakuma T, Wang Z-W, Babcock E, McCorkle K, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem. 2001;276:5629-35.
-
(2001)
J Biol Chem
, vol.276
, pp. 5629-5635
-
-
Lee, Y.1
Wang, M.-Y.2
Kakuma, T.3
Wang, Z.-W.4
Babcock, E.5
McCorkle, K.6
-
26
-
-
84895072502
-
Nutraceuticals and dyslipidaemia: Beyond the common therapeutics
-
1:CAS:528:DC%2BC2cXivVCjuw%3D%3D
-
Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, et al. Nutraceuticals and dyslipidaemia: Beyond the common therapeutics. Journal of Functional Foods. 2014;6:11-32.
-
(2014)
Journal of Functional Foods
, vol.6
, pp. 11-32
-
-
Scicchitano, P.1
Cameli, M.2
Maiello, M.3
Modesti, P.A.4
Muiesan, M.L.5
Novo, S.6
|